A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD

Abstract Background COPD is a devastating disease affecting millions worldwide. As disease pathogenesis includes both chronic pulmonary and systemic inflammation, antiinflammatory effects of systemically administered mesenchymal stem cells (MSCs) may decrease inflammation, resulting in improved lung...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest 2013-06, Vol.143 (6), p.1590-1598
Hauptverfasser:	Weiss, Daniel J., MD, PhD, Casaburi, Richard, PhD, MD, FCCP, Flannery, Robin, LeRoux-Williams, Michelle, PhD, Tashkin, Donald P., MD, FCCP
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Chi-Square Distribution Double-Blind Method Electrocardiography Female Humans Male Mesenchymal Stem Cell Transplantation Middle Aged Original Research Placebos Prospective Studies Pulmonary Disease, Chronic Obstructive - mortality Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary Disease, Chronic Obstructive - therapy Pulmonary/Respiratory Respiratory Function Tests Statistics, Nonparametric Surveys and Questionnaires Treatment Outcome United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!